Chirochem (Taizhou) Projects Trial Production Publicisation


凯诺科公司项目试生产公示


凯诺科(泰州)药物研发有限公司位于泰州滨江工业园区原料药公共服务平台G3幢标准厂房东南侧。公司的手性小分子新药研发及检测服务项目,于2018年8月20日取得《关于对凯诺科(泰州)药物研发有限公司手性小分子新药研发及检测服务项目环境影响报告表的批复》

Chirochem (Taizhou) is located at southeast of the standard plant Building G3 in the API Public Service Platform of Bingjiang Industrial Park. The company obtained the approval of the Environmental Impact Report Form for the Development and Testing Services of Chiral Small Molecule by Chirochem (Taizhou) from the local official environmental department on the 20th of August 2018.


项目自2018年11月12日开始施工建设,2019年4月10日完成建设施工。2019年4月20日开始, 我公司组织相关人员进行验收交付,同年6月30日完成验收交付。

The construction work was started from the 12th of November 2018 and completed on the 10th of April 2019. From the 20th of April 2019, the company organized the completion-based check, and the final acceptance inspection was finished on the 3rd of June 2019.


计划于2019年7月5日进行试生产,我司愿意接受社会各级人员的监督

The trial production is scheduled and will start from the 5th of July 2019. We are willing to accept the inspection and monitoring from all levels of the society.


特此公示!

Hereby publicised!

凯诺科(泰州)药物研发有限公司

Liverpool Chirochem (Taizhou)

2019年7月2日

2nd of July 2019